Long-term intensive insulin therapy in IDDM: Effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia

Diabetologia

Volumn 39, Issue 6, 1996, Pages 677-686

  Pampanelli, S ^a   Fanelli, C ^a   Lalli, C ^a   Ciofetta, M ^a   Del Sindaco, P ^a   Lepore, M ^a   Modarelli, F ^a   Rambotti, A M ^a   Epifano, L ^a   Di Vincenzo, A ^a   Bartocci, L ^a   Annibale, B ^b   Brunetti, P ^a   Bolli, G B ^a,c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Counterregulation; Glycaemic thresholds; Hypoglycaemia; Hypoglycaemia unawareness; IDDM; Intensive insulin therapy

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

3-HYDROXYBUTYRIC ACID; ADULT; ALANINE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; GLYCEROL; HEMOGLOBIN A, GLYCOSYLATED; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYDROXYBUTYRATES; HYPOGLYCEMIA; INSULIN; LACTIC ACID; MALE; NOREPINEPHRINE; PANCREATIC POLYPEPTIDE; PERCEPTION; RISK FACTORS;

EID: 0029895956     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00418539     Document Type: Article

References (43)

1. Brinchmann-Hansen O, Dahl-Jorgensen K, Sandivik L et al. (1992) Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ 304: 19-22
2. Reichard P, Nilsson B-Y, Rosenquist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304-309
3. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
4. Simonson D, Tamborlane W, De Fronzo R, Sherwin R (1985) Intensive insulin therapy reduces the counterregulatory hormone response to hypoglycemia in patients with type 1 diabetes. Arch Intern Med 103: 184-190
5. Amiel S, Sherwin R, Simonson D, Tamborlane W (1988) Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37: 901-907
6. Fanelli C, Epifano L, Rambotti AM et al. (1993) Meticulous prevention of hypoglycemia (near-)normalizes magnitude and glycemic thresholds of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with IDDM of short duration. Diabetes 42: 1683-1689
7. Fanelli C, Pampanelli S, Epifano L et al. (1994) Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of a rational, intensive insulin therapy in IDDM. Diabetologia 37: 1265-1276
8. Cryer PE (1992) Iatrogenic hypoglycemia as cause of hypoglycemia-associated autonomic failure in IDDM. A vicious circle. Diabetes 41: 255-260
9. Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. BMJ 285: 916-918
10. Bolli GB (1989) The pharmacokinetic basis of insulin therapy. Diab Res Clin Prac 6:S3-S16
11. Dimitriadis G, Gerich J (1983) Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6: 374-377
12. Pampanelli S, Torlone E, Lalli C et al. (1995) Improved post-prandial metabolic control after subcutaneous injection of a short-acting insulin analogue in IDDM of short duration with residual pancreatic β-cell function. Diabetes Care 18: 1452-1459
13. Bolli GB, Perriello G, Fanelli C, De Feo P (1993) Nocturnal blood glucose control in type 1 diabetes mellitus. Diabetes Care [Suppl 3] 16:71-89
14. The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the Diabetes Control Complications Trial. Am J Med 90: 450-459
15. Fanelli C, Pampanelli S, Epifano L et al. (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37: 797-807
16. De Feo P, Perriello G, Ventura MM et al. (1986) Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia 29: 475-480
17. McGuire E, Helderman J, Tobin R, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41: 565-573
18. Schwartz N, Clutter W, Shah S, Cryer P (1987) Glycemic threholds for activation of glucose counterregulatory systems are higher than the thresholds for symptoms. J Clin Invest 79: 777-781
19. Towler DA, Havlin CE, Craft S, Cryer PH (1993) Mechanisms of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42: 1791-1798
20. Fanelli C, De Feo P, Porcellati F et al. (1992) Adenergic mechanisms contribute to the late phase of hypolgycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 89: 2005-2013
21. Kohn A, Annibale B, Suriano G et al. (1985) Gastric acid and pancreatic polypeptide responses to modified sham feeding: indication of an increased basal vagal tone in a subgroup of duodenal ulcer patients. Gut 26: 776-782
22. Perriello G, Torlone E, Di Santo S et al. (1988) Effects of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31: 811-815
23. Zar J (1984) Biostatistical analysis. Englewood Cliffs, Prentice Hall
24. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44: 968-983
25. Heller S, Cryer P (1991) Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in humans. Diabetes 40: 223-226
26. Davis M, Shamoon H (1991) Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 73: 995-1001
27. Widom B, Simonson DC (1990) Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med 112: 904-912
28. Lingenfelser T, Renn W, Sommerwerck U et al. (1993) Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypolgycemia in IDDM patients. Diabetes 42: 610-618
29. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J (1993) Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42: 1233-1237
30. De Fronzo R, Hendler R, Christensen N (1980) Stimulation of counterregulatory hormonal response in diabetic man by a fall in glucose concentration. Diabetes 29: 125-131
31. Boyle PJ, Shwartz NS, Shah SD, Clutter WE, Cryer PE (1988) Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318: 1487-1492
32. Jacob RJ, Weber AB, Dziura J, Morgen J, Sherwin RS (1995) Brainstem dysfunction is provoked by less pronounced hypoglycemic stimulus in diabetic BB rats. Diabetes 44: 900-905
33. Gjedde A, Crone C (1981) Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 214: 456-457
34. McCall A, Fixman L, Fleming N et al. (1986) Chronic hypoglycemia increases brain glucose transport. Am J Physiol 251: E 442-E 447
35. Boyle P, Kempers S, O'Connor AM, Nagy RJ (1995) Brain glucose uptake and hypoglycemia unwareness in patients with insulin-dependent diabetes mellitus. N Engl J Med 333: 1726-1731
36. 1c without increase in the risk of severe hypoglycaemia. Diabetologia 38 [Suppl 1]: A 18 (Abstract)
37. Bolli GB, De Feo P, Compagnucci Pet al. (1983) Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32: 134-141
38. Cranston I, Lomas J, Maran A, MacDonald J, Amiel SA (1994) Restoration of hypoglycaemia unawareness in patients with long-duration of insulin-dependent diabetes. Lancet 344: 283-287
39. Dagogo-Jack S, Rattarasarn C, Cryer P (1994) Reversal of hypoglycemia unawareness, but not glucose counterregulation, in insulin dependent diabetes mellitus. Diabetes 43: 1426-1434
40. De Feo P, Perriello G, Torlone E et al. (1991) Evidence against important catecholamine compensation for absent glucagon counterregulation. Am J Physiol 260: E 203-E 212
41. Bottini P, Boschetti E, Pampanelli S et al. (1995) Response of plasma adrenaline to hypoglycaemia and exercise in IDDM with or without autonomie neuropathy. Diabetologia 38[Suppl 1]: A203
42. Dagogo Jack SE, Cryer PE (1993) Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 91: 819-828
43. Schwartz TW (1983) Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85: 1411-1425